The Bid

A Prescription For Healthcare Investing

11.18.2022 - By BlackRockPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Funding new drug development is challenging. Trials are expensive, complex, and lengthy, and only a fraction of the therapeutics that go into clinical trials will ever come out the other side approved. Sarah Shores welcomes Dr. Andrew Lo, economist, professor at MIT and co-founder of QLS Advisors, a Quantitative Life Sciences Company working to accelerate the pace of change in biomedicine.

More episodes from The Bid